Legis Daily

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

USA119th CongressS-4327| Senate 
| Updated: 4/16/2026
Tom Cotton

Tom Cotton

Republican Senator

Arkansas

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Timeline
Apr 16, 2026
Introduced in Senate
Apr 16, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • April 16, 2026
    Introduced in Senate


  • April 16, 2026
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.

USA119th CongressS-4327| Senate 
| Updated: 4/16/2026
Timeline
Apr 16, 2026
Introduced in Senate
Apr 16, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • April 16, 2026
    Introduced in Senate


  • April 16, 2026
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Tom Cotton

Tom Cotton

Republican Senator

Arkansas

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted